Femara (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Femara drug offered from Novartis Pharmaceuticals Corporation. This Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | letrozole |
| SUBSTANCE NAME: | LETROZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Femara HUMAN PRESCRIPTION DRUG Details:
| Item Description | Femara from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 1997-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0249_99d0c858-b812-443b-bb8a-5aacf551ce6b |
| PRODUCT NDC: | 0078-0249 |
| APPLICATION NUMBER: | NDA020726 |
Other LETROZOLE Pharmaceutical Manufacturers / Labelers:
